(Press-News.org) Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells. While islet transplantation has demonstrated promise, its widespread application is hampered by immune rejection, the necessity for lifelong immunosuppression, and a critical shortage of donor organs. This review posits that regenerative medicine, particularly strategies centered on stem cells and pancreatic progenitor cells, holds the key to a lasting cure. We explore innovative avenues for regenerating functional β-cells, with a focused analysis on the potential of pancreatic progenitor cells, the conversion of resilient α-cells, and the reprogramming of senescent β-cells. Despite persistent challenges such as immune attack and suboptimal cell differentiation, harnessing endogenous regenerative mechanisms and engineering immune-evasive cells present a transformative pathway toward restoring physiological insulin production and liberating patients from exogenous insulin dependence.
Introduction
The pathogenesis of T1D involves a selective autoimmune attack on pancreatic β-cells, sparing other endocrine cells like glucagon-producing α-cells. This selectivity underscores a fundamental opportunity: leveraging the innate resistance of non-β cells for therapeutic regeneration. Current treatments, including islet transplantation, are plagued by the recurrence of autoimmunity and organ donor scarcity. This review critically synthesizes past research to hypothesize that the future of T1D management lies in activating the body's own regenerative potential or creating an inexhaustible source of immune-tolerant β-cells from stem cells.
The Search for Elusive Pancreatic Stem Cells
A central quest in the field is the identification of endogenous pancreatic stem or progenitor cells in adults. While a dedicated stem cell niche akin to the bone marrow is absent in the mature pancreas, evidence points to the ductal epithelium as a reservoir of cells with progenitor-like capabilities. Advances in single-cell transcriptomics are now empowering researchers to identify and characterize these rare, transient cell populations, mapping their potential to differentiate into endocrine lineages. Concurrently, the derivation of β-like cells from pluripotent stem cells (e.g., embryonic or induced pluripotent stem cells) has progressed to clinical trials (e.g., ViaCyte, Vertex Pharmaceuticals), showing restored insulin production in patients. The dual approach—activating endogenous progenitors and transplanting externally differentiated cells—represents a powerful, scalable strategy.
Replicating β-cells and the Potential of Ductal Epithelium
Historically, β-cell mass expansion was thought to occur primarily through the replication of existing β-cells. However, this process is limited and often accompanied by temporary dedifferentiation, compromising function. In contrast, the process of neogenesis—the formation of new islets from progenitor cells—offers a more robust solution. The ductal epithelium exhibits remarkable plasticity, capable of generating new β-cells, especially in response to injury, metabolic stress, or specific signaling cues. Key pathways like Notch and Wnt, along with the inhibition of the Hippo pathway (activating YAP), have been shown to enhance this ductal-to-β-cell conversion, highlighting a viable therapeutic target for regeneration.
Unlocking Secrets from α-Cell Resilience
A pivotal insight for T1D therapy is the inherent resistance of α-cells to autoimmune destruction. This resilience is multi-faceted: α-cells express lower levels of key autoantigens, possess stronger anti-apoptotic signaling, exhibit greater endurance against inflammatory cytokines like interferon-gamma, and may reside in a more protected microenvironment within the islet. This inherent "immune privilege" provides a blueprint for protecting β-cells. Strategies such as molecular mimicry (engineering β-cells to express α-cell protective molecules), immune checkpoint modulation (e.g., introducing PD-1), and anti-inflammatory cytokine therapy (e.g., IL-10) are being explored to shield β-cells from immune attack.
Key Signaling Pathways in β-Cell Regeneration
Reversing T1D requires a deep understanding of the molecular pathways governing β-cell development and identity.
NGN3 (Neurogenin 3): A master regulator of endocrine differentiation, NGN3 reactivation in adult ductal or acinar cells can drive the formation of new, glucose-responsive β-like cells.
Wnt/β-catenin and Hippo/YAP: These pathways are crucial for progenitor cell proliferation, survival, and differentiation. Their targeted activation promotes the expansion and maturation of β-cell precursors.
GLP-1 (Glucagon-like peptide-1): Beyond its insulinotropic effects, GLP-1 enhances β-cell survival, proliferation, and even promotes the transdifferentiation of α-cells into β-like cells.
GDF11 (Growth differentiation factor 11): This factor shows promise in stimulating β-cell regeneration and may counteract age-related decline in regenerative capacity.
Bench-to-Bedside Strategies and Technical Hurdles
The translational pipeline is rich with diverse approaches, including stem cell-derived β-cells, autologous iPSC therapies, drug-induced endogenous regeneration (e.g., glucagon receptor antagonists), cellular reprogramming, and encapsulation technologies. However, significant hurdles remain. These include the functional immaturity of stem cell-derived β-cells, the risk of immune rejection even with matched cells, challenges in scaling up production under Good Manufacturing Practice, and the risk of tumorigenicity from residual pluripotent cells. Encapsulation devices face issues with fibrosis and limited nutrient diffusion, while gene-editing strategies like CRISPR, though promising for creating immune-evasive cells, raise concerns about off-target effects.
Future Directions and Conclusion
The future of T1D cure lies in integrated, systems-level approaches. This includes employing biomimetic scaffolds and organ-on-chip systems to improve β-cell maturation, using multi-omics to precisely map cell fates, and combining regenerative therapies with antigen-specific immunomodulation to create a tolerant microenvironment. Furthermore, research must address the neuroendocrine integration of regenerated β-cells and leverage artificial intelligence for personalized treatment strategies.
In conclusion, while challenges in scalability, safety, and immune compatibility are substantial, the convergence of stem cell biology, regenerative signaling, and immunoengineering is paving a concrete path toward a cure for T1D. The vision is shifting from lifelong insulin management to the restoration of endogenous, functional β-cell mass, offering the genuine prospect of insulin independence for patients.
Full text:
https://www.xiahepublishing.com/2472-0712/ERHM-2024-00002
The study was recently published in the Exploratory Research and Hypothesis in Medicine.
Exploratory Research and Hypothesis in Medicine (ERHM) publishes original exploratory research articles and state-of-the-art reviews that focus on novel findings and the most recent scientific advances that support new hypotheses in medicine. The journal accepts a wide range of topics, including innovative diagnostic and therapeutic modalities as well as insightful theories related to the practice of medicine. The exploratory research published in ERHM does not necessarily need to be comprehensive and conclusive, but the study design must be solid, the methodologies must be reliable, the results must be true, and the hypothesis must be rational and justifiable with evidence.
END
Statins have transformed heart health, saving millions of lives by lowering cholesterol and reducing the risk of heart attacks and strokes. But for many patients, these drugs come with a troubling downside: muscle pain, weakness and, in rare cases, severe muscle breakdown that can lead to kidney failure.
University of British Columbia researchers and their collaborators at the University of Wisconsin-Madison have now pinpointed the cause. Their findings, published last week in Nature Communications, could pave the way ...
SAN ANTONIO — November 26, 2025 — Engineers at Southwest Research Institute (SwRI) have developed a reliable testing methodology to study stochastic pre-ignition (SPI) in hydrogen-fueled internal combustion engines (H2-ICEs), offering the automotive industry tools to address challenges associated with hydrogen fuel and advance cleaner engine technologies.
Pre-ignition, where unintentional combustion occurs before spark timing, is disruptive and sometimes detrimental to engine performance and durability. While hydrogen's low ignition threshold is a suspected SPI factor, SwRI explored whether lubricant autoignition contributes to SPI in H2-ICEs.
“H2-ICEs ...
A study by researchers at the University of Wisconsin–Madison has revealed a previously unknown pathway plants use to detect gravity and orient the direction they grow in. Publishing this week in Proceedings of the National Academy of Sciences, the study may one day open the door for improvements in crop cultivation.
Prior studies have already established that a suite of genes, nicknamed LAZY, control a pathway plants use for detecting gravity. In a typical plant, cells within the stem use LAZY genes to detect the force of gravity. The plant can then guide the stem to grow upwards, branches to grow outwards, and roots to ...
Food quality and safety are crucial. However, conventional food-monitoring methods, including ribotyping and polymerase chain reaction, tend to be destructive and lengthy. These shortcomings limit their potential for broad applications. In this regard, surface-enhanced Raman scattering (SERS) sensing, with real-time, non-destructive, and high sensitivity capabilities, is a highly promising alternative.
In a new breakthrough, a team of researchers, led by Associate Professor Ji-Hwan Ha from the Department of Mechanical ...
Parkinson’s disease (PD) is an age-related, progressive neurodegenerative disorder. The hallmark of PD pathogenesis is the Lewy bodies (LBs) that accumulate in neurons in the substantia nigra region of the brain, damaging these neurons and leading to the motor symptoms of the disease. α-synuclein (α-syn), a misfolded protein, aggregates and forms fibrils, which leads to the formation of LBs. The exact molecular mechanism behind this aggregation process is yet to be uncovered. With an increasing number of elderly patients suffering from Parkinson’s and other neurodegenerative diseases ...
Power transmission lines (TLs) are ubiquitous, spanning diverse landscapes, including forests, agricultural regions, as well as mountains. Therefore, it is crucial to develop novel technologies to monitor their condition in terms of environmental infringement as well as sag estimation.
In a breakthrough, a team of researchers, led by Prof. Ki-Yong Oh, Associate Professor of Mechanical Engineering at Hanyang University, and Munsu Jeon, a PhD candidate in Mechanical Convergence Engineering at Hanyang University, has presented the first unmanned ...
CHICAGO – The brain’s waste-clearing system significantly declines in function with repeated head impacts, according to a new study of cognitively impaired professional boxers and mixed martial arts fighters. The findings will be presented next week at the annual meeting of the Radiological Society of North America (RSNA).
Sports-related traumatic brain injuries account for up to 30% of all brain injury cases, and boxing and mixed martial arts are major contributors. Repeated head impacts are risk factors ...
CHICAGO – An image-only artificial intelligence (AI) model for predicting the five-year risk of breast cancer provided stronger and more precise risk stratification than breast density assessment, according to a new study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).
Senior author Constance D. Lehman, M.D., Ph.D., professor of radiology at Harvard Medical School in Boston, Massachusetts, said traditional methods of assessing a woman’s risk for breast cancer, including age, family history, genetics and breast density, ...
A large-scale laboratory screening of human-made chemicals has identified 168 chemicals that are toxic to bacteria found in the healthy human gut. These chemicals stifle the growth of gut bacteria thought to be vital for health.
Most of these chemicals, likely to enter our bodies through food, water, and environmental exposure, were not previously thought to have any effect on bacteria.
As the bacteria alter their function to try and resist the chemical pollutants, some also become resistant to antibiotics such as ciprofloxacin. If this happens in the human gut, it could make infections harder to treat.
The new research, ...
EMBARGOED UNTIL 10:00 AM GMT / 05:00 ET WEDNESDAY 26 NOVEMBER 2025
Chemists design OLEDs that electrically flip the handedness of light
Researchers from the University of Oxford have for the first time discovered an approach to electrically switch organic LEDs (OLEDs) to emit either left- or right-handed circularly polarized light without changing the light-emitting molecules. This could be useful for a range of technological applications, from more energy efficient OLED displays, to optical information transfer. They describe their results in a study published today (26 Nov) in Nature Photonics.
Usually, the handedness of such ...
